bioAffinity Technologies (BIAF) Current Deferred Revenue (2023 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Current Deferred Revenue of $31140.0 for Q1 2026, up 27.6% year-over-year from $24404.0 in Q1 2025, and up 30.69% quarter-over-quarter from $23827.0 in Q4 2025.
bioAffinity Technologies (BIAF) Current Deferred Revenue (2023 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Current Deferred Revenue for 4 consecutive years, with $31140.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Deferred Revenue rose 27.6% year-over-year to $31140.0; the TTM figure through Mar 2026 stood at $31140.0 (up 27.6% YoY), while the FY2025 annual figure was $23827.0, down 2.36% from the prior year.
- Current Deferred Revenue climbed to $31140.0 in Q1 2026 per BIAF's latest filing, from $23827.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $43000.0 in Q2 2023 and bottomed at $23827.0 in Q4 2025.
- Historically, Current Deferred Revenue has averaged $28967.0 across 4 years, with a median of $25269.5 in 2024.
- Annual changes were most pronounced in 2024 — Current Deferred Revenue plunged 39.22% — and 2026, when it climbed 27.6%.
- bioAffinity Technologies' Current Deferred Revenue stood at $33058.0 in 2023, then dropped by 26.18% to $24404.0 in 2024, then slipped by 2.36% to $23827.0 in 2025, then jumped by 30.69% to $31140.0 in 2026.
- Business Quant data shows BIAF's Current Deferred Revenue at $31140.0 in Q1 2026, $23827.0 in Q4 2025, and $24404.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | bioAffinity Technologies | 1.78 Mn | -649,139.45 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31,140.00 |
| Mar 31, 2026 | 31,140.00 |
| Dec 31, 2025 | 42,405.00 |
| Sep 30, 2025 | 37,915.00 |
| Jun 30, 2025 | 24,404.00 |
| Mar 31, 2025 | 24,404.00 |
| Dec 31, 2024 | 24,404.00 |
| Sep 30, 2024 | 24,404.00 |
| Jun 30, 2024 | 26,135.00 |
| Mar 31, 2024 | 30,174.00 |
| Dec 31, 2023 | 33,058.00 |
| Sep 30, 2023 | 38,250.00 |
| Jun 30, 2023 | 43,000.00 |